Skip to main content
David Mischoulon, MD, Psychiatry, Boston, MA

DavidMischoulonMDPHD

Psychiatry • Boston, MA

Psychopharmacology, Psychosomatic Medicine

Professor of Psychiatry Harvard Medical School; Director of Depression Clinical and Research Program, MGH

Join to view full profile

Dr. Mischoulon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mischoulon's full profile

Already have an account?

  • Office

    15 Parkman St
    Massachusetts General Hospital Wac812
    Boston, MA 02114
    Phone+1 617-724-5198
    Fax+1 617-724-3028

Summary

  • Dr. David Mischoulon is a psychiatrist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from Boston University School of Medicine and has been in practice 23 years. He also speaks multiple languages, including Spanish and French. He specializes in psychopharmacology and is experienced in clinical research, integrative medicine, depressive disorders, health outcomes research, and acupuncture therapy.

Education & Training

  • Massachusetts General Hospital/McLean Hospital
    Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1995 - 1998
  • Steward Carney Hospital
    Steward Carney HospitalInternship, Internal Medicine, 1994 - 1995
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1994

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1997 - 2026
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Race and Ethnicity with Late-Life Depression Severity, Symptom Burden, and Care  
    David Mischoulon, Olivia I Okereke, JAMA Network Open
  • Research Paper Tachyphylaxis in Major Depressive Disorder: A Review of the Current State of Research  
    Gustavo Kinrys, Andrew A Nierenberg, George I Papakostas, David Mischoulon, Maurizio Fava, Marlene P Freeman, ScienceDirect
  • Adjunctive S-adenosylmethionine (SAMe) in Treating Non-Remittent Major Depressive Disorder: An 8-Week Double-Blind, Randomized, Controlled Trial,  
    David Mischoulon, MD, European Neuropsychopharmacology

Authored Content

  • Association of Race and Ethnicity with Late-Life Depression Severity, Symptom Burden, and CareMarch 2020

Press Mentions

  • Electroacupuncture Points to Improvements in Depression-Related Insomnia
    Electroacupuncture Points to Improvements in Depression-Related InsomniaJuly 7th, 2022
  • Omega-3 Fish Oil Supplements Don’t Help Prevent Depression, Clinical Trial Finds – Massachusetts General Hospital
    Omega-3 Fish Oil Supplements Don’t Help Prevent Depression, Clinical Trial Finds – Massachusetts General HospitalDecember 21st, 2021
  • Psychological Resilience Required
    Psychological Resilience RequiredJune 24th, 2021
  • Join now to see all

Grant Support

  • Omega-3 Fatty Acids For Treatment Of Major DepressionNational Institute Of Mental Health2006–2010
  • Effect Of Protein Or Carbohydrate Intake On Mood And Appetite Symptoms OfNational Center For Research Resources2006–2007
  • Effect Of Protein Or Carbohydrate Intake On Mood And Appetite Symptoms Of MildNational Center For Research Resources2005–2006
  • Omega-3 Fatty Acids In The Treatment Of DepressionNational Center For Complementary &Alternative Medicine2001–2005

Other Languages

  • Spanish, French

Dr. David Mischoulon, Dr. David Mischoulon, MD, Dr. D Mischoulon